baber/WOPTO huggingface dataset:
Patent NZ-536448-A (NZ)
Title: Syringe with conical portions of interengageable push rod and needle seat to conceal needle after use
Inventor: WU WEI-SHUI
Filed: 2004-11-08
Abstract: Disclosed is a safe syringe with push rod 2 having a part-conical portion 25 which is placed into a needle seat 3 which in turn is placed in a syringe tube 1. Complementary surfaces of the seat 3 and tube 1 ensure retention during Norman use. When the push rod portion 25 is forced into seat 3 the latter can be retracted with the push rod 2 which can then be broken off leaving the base of the push rod 21 resting above the lower internal lip of the tube 1. This conceals the needle and seat after use of the syringe.
Patent NZ-546036-A (NZ)
Title: Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
Inventor: FLOHR ALEXANDER
IPC: C07D223/16
Filed: 2004-09-27
Abstract: Disclosed are compounds of the general formula (I), wherein R4 is a) or b) and the remaining substituents are as defined in the specification; and pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof for the treatment of Alzheimer's disease.
Patent NZ-552604-A (NZ)
Title: Device for Providing the Position of a Flaw Indication on the Exterior of a Nozzle, a Pressure Vessel, and/or a Blend
Inventor: DONALDSON TERESA K
IPC: G01B11/26
Filed: 2005-07-26
Abstract: A measurement device capable of providing coordinates in at least two dimensions for a specified location on the exterior surface of a vessel is provided. The device includes: a base adapted to contact the exterior surface of the vessel, where the base is capable of being oriented at various positions on the exterior surface of the vessel; a rail extending from the base, which includes a measurement scale; an angle indicator for determining the angular position of the rail; a head slidably supported by the rail; and a laser carried by the head for projecting an image on the exterior surface of the vessel.
Patent NZ-553084-A (NZ)
Title: Extrusion apparatus and method for extruding high protein foodstuffs
Inventor: BOHNER HANS F
IPC: B29C48/405
Filed: 2005-08-19
Abstract: There is described a twin-screw extruder in which there are provided a pair of die hole sets which are aligned with the extrusion paths from each screw. This arrangement allows all the extrusion path lengths from a plane perpendicular to the screw ends to the outer ends of the die holes to be substantially the same. Preferably two sets of cutter blades cut extrudate at the die hole outlets of each set. The blades are arranged on a pair of rotary assemblies, the axes of rotation of which are substantially coaxial with the axes of rotation of the extruder screws. Optionally a pressure chamber, capable of sustaining a pressure of less than ambient, is in gas tight communication with the outlet of the extruder to receive extrudate to enhance expansion of the extrudate.
Patent NZ-554074-A (NZ)
Title: A water heater and a method of operating same
Inventor: PUSSELL PATRICK
IPC: F24D17/00
Filed: 2005-09-16
Abstract: A water heater (10) including a tank (12) adapted for mounting with its longitudinal axis substantially vertical and a duct (32) adapted for mounting with its longitudinal axis substantially vertical. The duct is positioned within the tank and extends through at least most of the height of the tank. The duct defines a first volume (34) within the duct interior and a second volume (36) between the duct exterior and the tank interior, the first volume being smaller than the second volume. The duct has at least one upper opening (38) at or near the top of the duct and at least one lower opening (40) at or near the bottom of the duct. The heater also has a heating element (44) within, or forming all or part of, the duct. The element extends at least substantially through the upper half of the duct. The heater also has an inlet (24) at or near the bottom of the tank and an outlet (22) at or near the top of the tank. In use, energising the heater element causes water to flow from the first volume to the second volume through the upper opening(s) and water to flow the second volume to the first volume through the lower opening(s).
Patent NZ-554212-A (NZ)
Title: Perorally administrable antimicrobial composition comprising an antibiotic drug and lactulose particles
Inventor: CHICHERIN DMITRY SERGEEVICH
IPC: A61K47/26
Filed: 2005-08-25
Abstract: Disclosed is an antimicrobial composition for peroral administration, an antibiotic drug selected from broad-spectrum penicillins, cephalosporins, tetracyclines, lincosamides, and macrolides, and also lactulose, at the ratio of 1:1-1:100, wherein the mean particle size of lactulose is between 100 nm and 200 µm.
Patent NZ-564157-A (NZ)
Title: Concentration of fatty acid alkyl esters by enzymatic reactions with glycerol
Inventor: SAEBO PER CHRISTIAN
IPC: A23D9/013
Filed: 2006-05-23
Abstract: Disclosed is a process for the separation of fatty acid alkyl esters comprising: (a) forming a mixture of at least two fatty acid alkyl esters, glycerol, and a catalytically effective amount of an enzyme; (b) treating the mixture at a reduced pressure in the presence of water under conditions such that the at least two fatty acid esters esterify with the glycerol at different rates. (c) separating the glycerides and the fatty acid alkyl fraction. Also disclosed is a composition produced by the process and its use as an animal feed, infant formula, or food product. Also disclosed is an enzymatic process for separating fatty acid alkyl esters, comprising the step of agitating the fatty acid alkyl esters in a mixture at a temperature effective to cause the glycerol to begin esterify the fatty acid alkyl esters at different rates, while removing volatile reaction products from the reaction mixture.
Patent NZ-573450-A (NZ)
Title: Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
Inventor: MITCHELL DARREN JASON
IPC: A61P1/00
Filed: 2007-06-26
Abstract: Disclosed is a compound of formula (I) and a salt thereof, wherein A is phenyl or a heteroaryl ring; R1 and R2 are independently H or alkyl; R3 is a phenyl, heteroaryl ring, or a heterocyclic ring; B is phenyl, heteroaryl ring or heterocyclic ring connected to the amide carbon via a carbon atom; Y is a bond, NH, N-alkyl, O, C=O, or CH2; R4 is hydrogen, alkyl or alkoxyalkyl. One of the preferred example of this compound of formula (I) is 6-(3-fluorophenyl)-N-methyl-N-(4-{ [(3S)-3-methyl-1-piperazinyl]methyl} phenyl)-3-pyridine carboxamide. These compounds are suitable for use in the treatment of a condition or disorder selected from gastroesophageal reflux disorders, functional dyspepsia, irritable bowel syndrome. constipation, intestinal pseudo-obstruction, paralytic ileus follovying surgery or other manipulation, emesis, gastric stasis or hypomotility caused by various diseases such as diabetes and orby the administration of other drugs, or in enterally fed patients, Crohn's disease, colitis, cachexia associated with advanced diseases such as cancer and/or the treatment thereof, appetite/metabolism related cachexia and other disorders such as incontinence.
Patent NZ-574550-A (NZ)
Title: An aminoisoquinoline thrombin inhibitor with improved bioavailability
Inventor: GILFILLAN ROBERT
IPC: A61K31/435
Filed: 2007-08-06
Abstract: Disclosed is the compound N-(2-oxo-2-propoxyethyl)-beta-phenyl-D-phenylalanyl-N-[(1- amino-6-isoquinolinyl)methyl]-L-prolinamide, represented by formula 1A, its intermediate N-(carboxymethyl)-beta-phenyl-D-phenylalanyl-N-[(1-amino-6-isoquinolinyl)methyl]-L-prolinamide or a pharmaceutically acceptable salt thereof and its use for treating and preventing thrombin mediated diseases.
Patent NZ-579402-A (NZ)
Title: Organic compounds for diagnosis and treatment of pathologies relating to the Hedgehog pathway
Inventor: KELLEHER JOSEPH
IPC: C07D401/06
Filed: 2008-03-13
Abstract: Disclosed is a substituted piperidine or piperazine compound of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) include: 6-[4-(4-Benzyl-phthalazin-1-yl)-piperazin-1-yl]-nicotinonitrile; 1-Benzyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-phthalazine and 6-Benzyl-4-methyl-3-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-pyridazine. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating a pathology relating to the Hedgehog pathway.
Patent NZ-584790-A (NZ)
Title: Device for the application of fibrin adhesive
Inventor: MANZANO RIERA JORGE MARIA
IPC: A61B17/03
Filed: 2010-04-20
Abstract: A device for applying the two components of a fibrin adhesive to a treatment site comprises a double syringe support 1 and a plunger 2. The syringe support 1 comprises two parallel cylindrical housings that receive the corresponding syringes 4 40, and a passage 12 for receiving the plunger 2. The cross-section of the plunger 2 receiving passage 12 is minimum at the centre and maximum at the ends.
Patent NZ-585629-A (NZ)
Title: Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
Inventor: GABETTA BRUNO
IPC: C07D305/14
Filed: 2005-10-07
Abstract: Disclosed is a process for the preparation of Docetaxel, wherein the process comprises the steps of: (a) preparation of 10-deacetyl-bis-7,10- trichioroacetylbaccatin III represented by formula (VI) with a content of the corresponding 7- or 10 mono-trichioroacetyl derivatives lower than 0.1% as determined by HPLC, comprising the silica gel chromatography of a reaction mixture producing (VI); and (b) conversion of (VI) to Docetaxel, wherein the intermediate represented by formula (I) is reacted with di-tert-butyl dicarbonate to produce Docetaxel.
Patent NZ-586642-A (NZ)
Title: Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
Inventor: KONAKANCHI DURGA PRASAD
IPC: A61K31/519
Filed: 2009-01-12
Abstract: Disclosed are substituted pyrazolo pyrimidine compounds of formula I, salts thereof, and methods for their preparation. Specific examples of compounds of formula I include: (4-methoxy-benzyl-[1-(3-ethynyl-phenyl)-1H-pyrazolo [3,4-d] pyrimidine-4yl)-amine, [1-(3-trimethylsilanyl ethynyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidine-4yl)-(3,4,5-trimethoxybenzyl)-amine, and [4-(3-morpholin-4-yl-propoxy)-benzyl]-[1-(3-iodo-phenyl)-1H-pyrazolo[3,4-d]pyrimidine-4yl)-amine. Specifically disclosed is a synthetic method for N-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-1-(3,5-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine. Also disclosed is the use of a compound of formula I for treating lung cancer, squamous cell cancer, bladder cancer, gastric cancer, pancreatic cancer, breast cancer, head cancer, neck cancer, esophageal cancer, brain cancer, gynecological cancer, prostate cancer, kidney cancer, leukemia, lymphoma or thyroid cancer.
Patent NZ-592448-A (NZ)
Title: Method and apparatus for limiting growth of eye length
Inventor: NEITZ JAY
IPC: A61F9/00
Filed: 2009-12-21
Abstract: Disclosed are therapeutic intervention devices for patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders including artificial blurring lenses and wavelength inhibiting lenses.
Patent NZ-599159-A (NZ)
Title: Package for cushioning food product
Inventor: STRILICH ERIK M
IPC: B65D75/30
Filed: 2010-09-27
Abstract: 599159 A packaged food product 10 comprises a rigid tray 12 having a bottom wall 16 and an upstanding sidewall 18 that terminates at a flange 24 extending about the periphery of the sidewall 18, the bottom wall 16 and upstanding sidewall 18 defining an interior of the tray 12 and the bottom wall 16 having a plurality of raised protuberances 48. A food product 44 is disposed in the interior of the tray and supported by the plurality of raised protuberances 48. The food product 44 has a substantially planar bottom surface, a side surface and a top surface with a plurality of displaceable toppings. The raised protuberances 48 act to cushion the bottom surface of the food product 44. A first flexible film layer 40 vacuum seals the food product 44 to the tray 12 and restricts movement of the displaceable toppings. The first flexible film layer 40 contacts the top surface and at least a portion of the side surface of the food product, and forms a peelable heat-seal with the flange 24 of the tray 12. A second flexible film layer 42 is positioned over the tray 18 and the first flexible film layer 40 and sealed to the first film layer 40 with a permanent seal coextensive with the peelable heat-seal between the first flexible film layer 40 and the flange 24 of the tray 12. The second flexible film layer 42 is spaced from the first flexible film layer 40 inwardly of the flange 24 of the tray 12 with a gas layer there between that to cushions the top surface of the food product
Patent NZ-600376-A (NZ)
Title: Elite event ee-gm3 and methods and kits for identifying such event in biological samples
Inventor: MASON JUSTIN THOMAS
IPC: C12Q1/68
Filed: 2010-11-23
Abstract: Disclosed is a soybean plant, plant cell, tissue, or seed, comprising in their genome event EE-GM3 characterised by a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 2 and a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 3, or the complement of said sequences, wherein the sequences are as defined in the complete specification.
Patent NZ-602517-A (NZ)
Title: Agent for treating disease
Inventor: GERMER MATTHIAS
IPC: A61K39/395
Filed: 2009-03-10
Abstract: Disclosed is the use of a humanized anti-CD4 antibody capable of activating CD4+CD25+ regulatory T cells for the manufacture of a pharmaceutical composition for treating an autoimmune disease in a subject, wherein the humanized anti-CD4 antibody comprises an H chain V domain, an L chain V domain and an IgG 1 constant domain wherein: (a) the H chain V domain compnses the sequences DCRMY, VISVKSENYGANYAESVRG and SYYRYDVGAWFAY, and the L chain Vdomain compnses the sequences RASKSVSTSGYSYIY, LASILES and QHSRELPWT; and/or (b) the H chain V domain has at least 90% sequence identity with SEQ ID No: 1 and the L chain V domain has at least 90% sequence identity with SEQ ID No: 2, and wherein the composition is to be administered to the subject in a dose of the humanized anti-CD4 antibody of from 20 mg to 200 mg; 8 to 60 mg/m2 body surface area of the subject; or 0.2 to 2 mg/kg. Further disclosed is a pharmaceutical composition comprising the antibody as defined above wherein the composition is in a volume of 1 ml to 3 ml and the humanized anti-CD4 antibody is present in the composition at a concentration of from 20 to 150 mg/ml; or (ii) the composition is in a volume of 15 to 25 ml and the humanized anti-CD4 antibody is present in the composition at a concentration of approximately 10 mg/ml or approximately 12.5 mg/ml.
Patent NZ-607996-A (NZ)
Title: Substituted nucleotide analogs
Inventor: SMITH DAVID BERNARD
IPC: C07H19/20
Filed: 2011-09-19
Abstract: 607996, Disclosed herein are amidothiophosphate or phosphorothioate nucleotide analogs, methods of synthesizing said nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the nucleotide analogs.
Patent NZ-612221-A (NZ)
Title: Ectoparasiticidal active substance combinations
Inventor: TURBERG ANDREAS
IPC: A61P33/00
Filed: 2011-12-19
Abstract: The disclosure relates products composed of a component A, a compound of general formula (I) in which the substitution pattern is disclosed within the specification, and component B an active compound of one of the following active compound groups: (I-2) GABA-gated chloride channel antagonists; (I-3) sodium channel modulators/voltage-dependent sodium channel blockers; (I-4) nicotinergic acetylcholine receptor agonists; (I-5) allosteric acetylcholinereceptor modulators (agonists); (I-6) chloride channel activators; (I-17) octopaminergic agonists;(I-25) synergists such as MGK264 and piperonyl butoxide (PBO). These products are for use against ectoparasites on animals. Examples of component A include: 4-(7 -chloro-,3-benzodioxol-5-yl)-1-(3-ethoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine 4-(7 -chloro-1,3-benzodioxol-5-yl)-1-(3-methoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine 4-(7-chloro-1,3-benzodioxol-5-yl)-1-(3-methoxypyrazin-2-yl)-3-methyl-1H-pyrazole-5-amine 4-(7-chloro-1,3-benzodioxol-5-yl)-1-(3-ethoxypyrazin-2-yl)-3-ethyl-1H-pyrazole-5-amine 4-(7-chloro-1,3-benzodioxol-5-yl)-1-(3-methoxypyrazin-2-yl)-3-cyclopropyl-1H-pyrazole-5-amine 4-(7-bromo-1,3-benzodioxol-5-yl)-1-(3-ethoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine 4-(7-bromo-1,3-benzodioxol-5-yl)-1-(3-methoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine 4-(7-bromo-1,3-benzodioxol-5-yl)-1-(3-ethoxypyrazin-2-yl)-3-ethyl-1H-pyrazole-5-amine 1-(3-ethoxypyrazin-2-yl)-3-(triluoromethyl)-4-[7-(trifluoromethyl)-1,3-benzodioxol-5-yl]-1H-pyrazole-5-amine 4-(3,5-dichloro-4-methoxyphenyl )-1-(3-ethoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine 4-[3,5-dichloro-4-(dimethylamino)phenyl]-1-(3-ethoxypyrazin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-amine:
Patent NZ-631131-A (NZ)
Title: Reconstituted hdl formulation
Inventor: VUCICA YVONNE
IPC: A61P3/06
Filed: 2013-10-31
Abstract: Discloses a reconstituted high density lipoprotein (rHDL) formulation comprising an apolipoprotein or a fragment thereof, a lipid and a lyophilisation stabiliser, wherein the ratio between the apolipoprotein and the lipid is from about 1:20 to about 1:120 (mol:mol) and the lyophilisation stabiliser comprises one or more selected from the group consisting of a sugar, a sugar alcohol and an amino acid present in a concentration from about 1.0% to less than 6.0% (w/w of rHDL formulation).
Patent NZ-705352-A (NZ)
Title: Flow meter assembly
Inventor: PEARSON DAMIEN VERNON
IPC: G12B9/00
Filed: 2010-08-18
Abstract: An acoustic flow meter assembly for a pipe includes at least three pairs 252, 256, 260, 262, and 264, 266 of acoustic transducers, the respective transducers of each pair being located on opposite sides of the pipe and offset longitudinally from each other along the pipe to provide upstream and downstream transducers. Each pair of transducers have their acoustic paths 270, 274, 276 intersecting at a point 278 along an axis of the pipe to provide redundancy in measuring flow through the pipe when one of the transducers fails.
Patent NZ-710361-A (NZ)
Title: Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities
Inventor: PUIG DURAN CARLOS
IPC: C07D409/14
Filed: 2014-02-27
Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives of formula (I) and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof with activity as dual β2 adrenergic receptor agonists and M3 muscarinic receptor antagonists.
Patent NZ-710557-A (NZ)
Title: Method for improving viscosity, solubility, and particle size of milk protein concentrates
Inventor: PETERSEN BRENT
IPC: B01F23/80
Filed: 2014-01-15
Abstract: Disclosed is a method for decreasing viscosity, increasing solubility and decreasing particle size of milk proteins by admixing milk protein with at least one transglutaminase and drying by spray drying.
Patent NZ-713292-A (NZ)
Title: Campaign optimization for experience content dataset
Inventor: MULLINS BRIAN
IPC: H04N5/262
Filed: 2014-03-12
Abstract: A server for campaign optimization is described. An experience content dataset is generated for an augmented reality application of a device based on analytics results. The analytics results are generated based on analytics data received from the other devices. The experience content dataset is provided to the device. The device recognizes a content identifier of the experience content dataset and generates an interactive experience with a presentation of virtual object content that is associated with the content identifier.
Patent NZ-728139-A (NZ)
Title: Heat pump system
Inventor: LIU WEI
IPC: F25B30/00
Filed: 2014-07-17
Abstract: Provided is a heat pump system (10, 10A) for a conditioned space comprising a first thermal fluid circuit adapted to selectably operate to circulate a thermal fluid therein, and a second thermal fluid circuit adapted to selectably operate to circulate the thermal fluid therein. The first thermal fluid circuit may comprise a compressor (15), a first heat exchanger (11), and a passage (55) of a heat accumulator (50). The second thermal fluid circuit may bypass the first heat exchanger (11), or the passage (55) of the heat accumulator (50), or both. The second thermal fluid circuit may comprise the compressor (15), and a second heat exchanger (12). During defrosting, a thermal fluid may be simultaneously circulated through the first and second thermal fluid circuits in order to provide heat both for defrosting the second heat exchanger (12) and heating a conditioned space.
Patent NZ-728785-A (NZ)
Title: Dithiocarbamate microbiocides and uses thereof
Inventor: SUMRALL THEODORE
IPC: A01N37/00
Filed: 2015-07-30
Abstract: The compositions and methods for control of microbial growth, for example, in oil and gas field fluids. The present invention also relates to microbicides, and more particularly, to the use of biocides in gas and oil field fluids.
Patent NZ-734642-A (NZ)
Title: Cartridge for an aerosol-generating system
Inventor: WIDMER JEAN-MARC
IPC: A24F47/00
Filed: 2016-04-28
Abstract: There is provided a cartridge for an aerosol-generating system. The cartridge includes a housing for holding an aerosol-forming substrate, the housing having an open end such that an opening of the housing is defined by the open end, and a heater assembly. The heater assembly includes at least one heater element fixed to the housing and extending across the opening of the housing. The at least one heater element defines a plurality of apertures for allowing fluid to pass through the at least one heater element, the plurality of apertures having different sizes. There is also provided a cartridge in which the at least one heater element comprises an array of electrically conductive filaments extending along its length and a plurality of transverse filaments extending transversely to the electrically conductive filaments. At least some of the transverse filaments extend across only part of the width of the at least one heater element and are staggered along the length of the at least one heater element. This provides a heater assembly which is inexpensive, efficient and robust.
Patent NZ-749946-A (NZ)
Title: Novel compound or pharmaceutically acceptable salt thereof
Inventor: YOSHIDA MINORU
IPC: C07D471/10
Filed: 2017-06-30
Abstract: 2- (Piperidin-1-yl) pyrimidin-4 (3H) -ones characterized by having a 1,8-diazaspiro [4.5] deca-3-ene, 1-oxa-8-azaspiro [4.5] deca-3-ene, 2,8-diazaspiro [4.5] deca-3-ene, 2-oxa-8-azaspiro [4.5] deca-3-ene, 2,9-diazaspiro [5.5] undeca-3-ene, 1-oxa-9-azaspiro [5.5] undeca-3-ene, 1,9-diazaspiro [5.5] undeca-4-ene, or 3,9-diazaspiro [5.5] undeca-1-ene structure represented by general formula (1), or a pharmaceutically acceptable salt thereof.